<DOC>
	<DOCNO>NCT02121899</DOCNO>
	<brief_summary>This registry intend measure effect myPlan Lung Cancerâ„¢ test influence treatment decision Oncologists added standard clinical-pathological parameter patient early stage NSCLC . The sponsor conduct two parallel registry , one direct Surgeons ( ONC003 ) Oncologists ( ONC006 ) . This registry specific Oncologists ( ONC006 ) .</brief_summary>
	<brief_title>Registry Measuring Impact RNA Expression Testing Treatment Decisions Early Stage Lung Cancer Assessing Disease-free Survival With Long-term Follow-up ( ONC006 )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Diagnosis early stage nonsmall cell lung adenocarcinoma Subpopulation staging ( IA , IB IIA ) judge standard practice investigational site Resection tumor within previous 2 month enrollment ECOG performance 02 A minimum life expectancy six month Exclusion Criteria Previous myPlan Lung Cancer test perform Preoperative radiation chemotherapy NSCLC Postoperative radiation chemotherapy NSCLC Enrollment separate clinical trial restrict treatment option Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Registry</keyword>
</DOC>